Nominations Sought for CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment
The Centers for Disease Control and Prevention (CDC) is soliciting nominations for possible membership on the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC).The 18-member Advisory Committee provides advice to the HHS Secretary, CDC’s Director, and HRSA’s Administrator on objectives, strategies, policies, and priorities for HIV, Viral Hepatitis, and STD prevention and treatment efforts. Nominees should be experts in HIV/AIDS, Viral Hepatitis and STD prevention, control and treatment. Experts in the disciplines of epidemiology, laboratory practice, immunology, infectious diseases, drug abuse, behavioral science, health education, healthcare delivery, state health programs, clinical care, preventive health, medical education, health services and clinical research, healthcare financing, and other related disciplines will be considered. At least four of the committee members must be living with HIV/AIDS. Selected members may be invited to serve for terms of up to four years.
The HHS policy stipulates that committee membership be balanced in terms of professional training and background, points of view represented, and the committee's function. Consideration is given to a broad representation of geographic areas within the United States, with equitable representation of the sexes, ethnic and racial minorities, and persons with disabilities. Nominees must be U.S. citizens and cannot be full-time employees of the U.S. Government. All nominations must be postmarked by April 30.
For more information on CHAC and its members as well as the nomination process, read this Federal Register announcement and visit the committee’s webpage.